Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (Neurokinin 1) receptor antagonist administration: A review

Current Drug Targets

Volumn 7, Issue 2, 2006, Pages 187-201

  Guiard, Bruno P ^a   Lanfumey, Laurence ^b   Gardier, Alain M ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Microdialysis; NK1 receptors; Selective Serotonin Reuptake Inhibitors; Substance P

Indexed keywords

17ALPHA ETHYNYL 17BETA HYDROXY 5ALPHA ANDROSTANO[3,2 B]PYRIMIDO[1,2 A]BENZIMIDAZOLE; 2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 3 (2 METHOXY 5 TRIFLUOROMETHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; 5 [[2 [1 [3,5 BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY] 3 (4 FLUOROPHENYL) 4 MORPHOLINYL]METHYL] N,N DIMETHYL 1H 1,2,3 TRIAZOLE 4 METHANAMINE; ANTIDEPRESSANT AGENT; APREPITANT; AUTORECEPTOR; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PINDOLOL; REBOXETINE; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; UNINDEXED DRUG; VENLAFAXINE; VOFOPITANT;

BODY WEIGHT DISORDER; CLINICAL TRIAL; DEPRESSION; DORSAL RAPHE NUCLEUS; DROWSINESS; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; ELECTROPHYSIOLOGY; HEADACHE; HUMAN; IN VIVO STUDY; KNOCKOUT MOUSE; LOCUS CERULEUS; META ANALYSIS; MICRODIALYSIS; MONOAMINERGIC SYSTEM; MONOTHERAPY; MOUSE; NAUSEA; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOLOGICAL BLOCKING; REMISSION; REVIEW; SEXUAL DYSFUNCTION; SYSTEMATIC REVIEW; WEIGHT GAIN; ANIMAL; DRUG ANTAGONISM; METABOLISM; RAPHE NUCLEUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; DRUG SYNERGISM; LOCUS COERULEUS; MICE; MICRODIALYSIS; RAPHE NUCLEI; RECEPTORS, NEUROKININ-1; SEROTONIN; SEROTONIN UPTAKE INHIBITORS;

EID: 33644865629     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945006775515428     Document Type: Review

References (132)

1. Montgomery, S.A., Huusom, A.K. and Bothmer, J. (2004) Neuropsychobiology, 50,57-64.
2. Frazer, A. (1997) J. Clin. Psychopharmacol., 17(Suppl 1), 2S-18S.
3. Burrows, G.D., Maguire, K.P. and Norman, T.R. (1998) J. Clin. Psychiatry, 59(Suppl 14),4-7.
4. Stahl, S.M. (1998) J. Clin. Psychiatry, 59(Suppl 18), 23-9.
5. Wong, M.L. and Licinio, J. (2001) Nat. Rev. Neurosci., 2, 343-51.
6. Romero, L. and Artigas, F. (1997) J. Neurochem., 68, 2593-603.
7. Hervas, I., Bel, N., Fernandez, A.G., Palacios, J.M. and Artigas, F. (1998) Naunyn. Schmiedebergs Arch. Pharmacol., 358, 315-22.
8. Arborelius, L., Linner, L., Wallsten, C., Ahlenius, S. and Svensson, T.H. (2000) Psychopharmacology (Berl.), 151, 77-84.
9. Brousse, G., Schmitt, A., Chereau, I., Eschalier, A., Dubray, C. and Llorca, P.M. (2003) Encephale, 29,338-50.
10. Ballesteros, J. and Callado, L.F. (2004) J. Affect Disord., 79, 137-47.
11. Moreno, F.A., Gelenberg, A.J., Bachar, K. and Delgado, P.L. (1997) J. Clin. Psychiatry, 58, 437-9.
12. Maes, M., Libbrecht, I., van Hunsel, F., Campens, D. and Meltzer, H.Y. (1999) J. Clin. Psychopharmacol., 19, 177-82.
13. Perez, V., Soler, J., Puigdemont, D., Alvarez, E. and Artigas, F. (1999) Arch. Gen. Psychiatry, 56, 375-9.
14. Boschert, U., Amara, D.A., Segu, L. and Hen, R. (1994) Neuroscience, 58, 167-82.
15. Adell, A., Celada, P. and Artigas, F. (2001) J. Neurochem., 79, 172-82.
16. Sari, Y. (2004) Neurosci. Biobehav. Rev., 28, 565-82.
17. Engel, G., Gothert, M., Hoyer, D., Schlicker, E. and Hillenbrand, K. (1986) Naunyn. Schmiedebergs Arch. Pharmacol., 332, 1-7.
18. Gothert, M., Schlicker, E., Fink, K. and Classen, K. (1987) Arch. Int. Pharmacodyn. Ther., 288, 31-42.
19. Trillat, A.C., Malagie, I., Scearce, K., Pons, D., Anmella, M.C., Jacquot, C., Hen, R. and Gardier, A.M. (1997) J. Neurochem., 69, 2019-25.
20. Clark, M.S., Sexton, T.J., McClain, M., Root, D., Kohen, R. and Neumaier, J.F. (2002) J. Neurosci., 22, 4550-62.
21. Hjorth, S., Bengtsson, H.J., Kullberg, A., Carlzon, D., Peilot, H. and Auerbach, S.B. (2000) J. Psychopharmacol, 14, 177-85.
22. Gardier, A.M., David, D.J., Jego, G., Przybylski, C., Jacquot, C., Durier, S., Gruwez, B., Douvier, E., Beauverie, P., Poisson, N., Hen, R. and Bourin, M. (2003) J. Neurochem., 86, 13-24.
23. Hokfelt, T., Broberger, C., Xu, Z.Q., Sergeyev, V., Ubink, R. and Diez, M. (2000) Neuropharmacology, 39, 1337-56.
24. Holmes, A., Heilig, M., Rupniak, N.M., Steckler, T. and Griebel, G. (2003) Trends Pharmacol. Sci., 24, 580-8.
25. Stout, S.C., Owens, M.J. and Nemeroff, C.B. (2001) Annu. Rev. Pharmacol. Toxicol., 41, 877-906.
26. Herpfer, I. and Lieb, K. (2005) CNS Drugs, 19, 275-93.
27. Mantyh, P.W. (2002) J. Clin. Psychiatry, 63 (Suppl 11), 6-10.
28. Mantyh, P.W., Johnson, D.J., Boehmer, C.G., Catton, M.D., Vinters, H.V., Maggio, J.E., Too, H.P. and Vigna, S.R. (1989) Proc. Natl. Acad. Sci. USA, 86, 5193-7.
29. Saffroy, M., Torrens, Y., Glowinski, J. and Beaujouan, J.C. (2003) Neuroscience, 116, 761-73.
30. Leger, L., Gay, N. and Cespuglio, R. (2002) Neurosci. Lett., 323, 146-50.
31. Lacoste, B., Riad, M., Watkins, K. and Descarries, L. (2004) 34th Annual Meeting of Neuroscience, Abs: 620.4.
32. Froger, N., Gardier, A.M., Moratalla, R, Alberti, I., Lena, I., Boni, C., De Felipe, C., Rupniak, N.M., Hunt, S.P., Jacquot, C., Hamon, M. and Lanfumey, L. (2001) J. Neurosci., 21, 8188-97.
33. Santarelli, L., Gobbi, G., Debs, P.C., Sibille, E.T., Blier, P., Hen, R. and Heath, M.J. (2001) Proc. Natl. Acad. Sci. USA, 98, 1912-7.
34. Commons, K.G. and Valentino, R.J. (2002) J. Comp. Neurol, 447, 82-97.
35. Liu, R., Ding, Y. and Aghajanian, G.K. (2002) Neuropsychopharmacology, 27, 329-40.
36. Ma, Q.P. and Bleasdale, C. (2002) Neuroreport, 13, 1809-12.
37. Charara, A. and Parent, A. (1998) J. Chem. Neuroanat., 15, 111-27.
38. Sergeyev, V., Hokfelt, T. and Hurd, Y. (1999) Neuroreport, 10, 3967-70.
39. Guyenet, P.G. and Aghajanian, G.K. (1977) Brain Res., 136, 178-84.
40. Cheeseman, H.J., Pinnock, RD. and Henderson, G. (1983) Eur. J. Pharmacol., 94, 93-9.
41. Tamiya, R., Inoue, K. and Takagi, H. (1994) Osaka City Med. J., 40, 1-11.
42. Ribeiro-da-Silva, A. and Hokfelt, T. (2000) Neuropeptides, 34, 256-71.
43. Nakaya, Y., Kaneko, T., Shigemoto, R., Nakanishi, S. and Mizuno, N. (1994) J. Comp. Neurol., 347, 249-74.
44. Hahn, M.K. and Bannon, M.J. (1999) Neuroscience, 94, 1183-8.
45. Chen, L.W., Wei, L.C., Liu, H.L. and Rao, Z.R. (2000) Brain Res., 873, 155-9.
46. Beaujouan, J.C., Torrens, Y., Saffroy, M., Kemel, M.L. and Glowinski, J. (2004) Peptides, 25, 339-57.
47. De Felipe, C., Herrero, J.F., O'Brien, J.A., Palmer, J.A., Doyle, C.A., Smith, A.J., Laird, J.M., Belmonte, C., Cervero, F. and Hunt, S.P. (1998) Nature, 392, 394-7.
48. Guiard, B.P., Przybylski, C., Guilloux, J.P., Seif, I., Froger, N., De Felipe, C., Hunt, S.P., Lanfumey, L. and Gardier, A.M. (2004) J. Neurochem., 89, 54-63.
49. Guiard, B., Froger, N., Hamon, M., Gardier, A.M. and Lanfumey, L. (2005) J. Neurochem., (in press).
50. David, D.J., Froger, N., Guiard, B., Przybylski, C., Jego, G., Boni, C., Hunt, S.P., De Felipe, C., Hamon, M., Jacquot, C., Gardier, A.M. and Lanfumey, L. (2004) Eur. J. Pharmacol., 492, 41-8.
51. Benveniste, H. and Huttemeier, P.C. (1990) Prog. Neurobiol., 35, 195-215.
52. Bortolozzi, A., Amargos-Bosch, M., Toth, M., Artigas, F. and Adell, A. (2004) J. Neurochem., 88, 1373-9.
53. Gardier, A.M., Malagie, I., Trillat, A.C., Jacquot, C. and Artigas, F. (1996) Fundam. Clin. Pharmacol., 10, 16-27.
54. Ungerstedt, U. (1991) J. Intern. Med., 230, 365-73.
55. Bert, L., Favale, D., Jego, G., Greve, P., Guilloux, J.P., Guiard, B.P., Gardier, A.M., Suaud-Chagny, M.F. and Lestage, P. (2004) J. Neurosci. Methods, 140, 53-7.
56. Rimon, R, Le Greves, P., Nyberg, F., Heikkila, L., Salmela, L. and Terenius, L. (1984) Biol. Psychiatry, 19, 509-16.
57. Olsson, A., Regnell, G., Traskman-Bendz, L., Ekman, R. and Westrin, A. (2004) Eur. Neuropsychopharmacol., 14, 479-85.
58. Bondy, B., Baghai, T.C., Minov, C., Schule, C., Schwarz, M.J., Zwanzger, P., Rupprecht, R. and Moller, H.J. (2003) Biol. Psychiatry, 53, 538-42.
59. Baby, S., Nguyen, M., Tran, D. and Raffa, R.B. (1999) J. Clin. Pharm. Ther., 24, 461-9.
60. Lieb, K., Walden, J., Grunze, H., Fiebich, B.L., Berger, M. and Normann, C. (2004) Pharmacopsychiatry, 37, 238-9.
61. Herpfer, I. and Lieb, K. (2003) World J. Biol. Psychiatry, 4, 56-63.
62. Stockmeier, C.A., Shi, X., Konick, L., Overholser, J.C., Jurjus, G., Meltzer, H.Y., Friedman, L., Blier, P. and Rajkowska, G. (2002) Neuroreport, 13, 1223-7.
63. Burnet, P.W. and Harrison, P.J. (2000) Biol. Psychiatry, 47, 80-3.
64. Arinami, T., Li, L., Mitsushio, H., Itokawa, M., Hamaguchi, H. and Toru, M. (1996) Biol. Psychiatry, 40, 1122-7.
65. Furlong, R.A., Keramatipour, M., Ho, L.W., Rubinsztein, J.S., Michael, A., Walsh, C., Paykel, E.S. and Rubinsztein, D.C. (2000) Am. J. Med. Genet., 96, 733-5.
66. Meira-Lima, IN., Pereira, A.C., Mota, G.F., Krieger, J.E. and Vallada, H. (2000) Neurosci. Lett., 293, 103-6.
67. Pauls, J., Bandelow, B., Ruther, E. and Kornhuber, J. (2000) J. Neural. Transm., 107, 1361-6.
68. Baghai, T.C., Schule, C., Zwanzger, P., Minov, C., Schwarz, M.J., de Jonge, S., Rupprecht, R. and Bondy, B. (2001) Mol. Psychiatry, 6, 258-9.
69. Hong, C.J., Wang, Y.C. and, Tsai, S.J. (2002) J. Neural. Transm., 109, 1209-14.
70. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F. (1990) J. Clin. Invest., 86, 1343-6.
71. Tiret, L., Rigat, B., Visvikis, S., Breda, C., Corvol, P., Cambien, F. and Soubrier, F. (1992) Am. J. Hum. Genet., 51, 197-205.
72. Baghai, T.C., Schule, C., Zill, P., Deiml, T., Eser, D., Zwanzger, P., Ella, R., Rupprecht, R. and Bondy, B. (2004) Neurosci. Lett., 363, 38-42.
73. Gradin, K., Qadri, F., Nomikos, G.G., Hillegaart, V. and Svensson, T.H. (1992) Eur. J. Pharmacol., 218, 363-7.
74. Bert, L., Rodier, D., Bougault, I., Allouard, N., Le-Fur, G., Soubrie, P. and Steinberg, R. (2002) Synapse, 43, 62-9.
75. Reisine, T., Soubrie, P., Artaud, F. and Glowinski, J. (1982) Brain Res., 236, 317-27.
76. Valentino, R.J., Bey, V., Pernar, L. and Commons, K.G. (2003) J. Neurosci., 23, 7155-9.
77. Valentino, R.J. and Commons, K.G. (2005) Neuropeptides, 39, 1-8.
78. Guiard, B., Guilloux, J., Reperant, C., Seif, I., Lanfumey, L. and Gardier, A.M (2004) 34th Annual Meeting of Neuroscience Abs: 628.7.
79. Felten, D.L. and Harrigan, P. (1980) Neurosci. Lett., 16, 275-80.
80. Kramer, M.S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J.J., Reines, S.A., Liu, G., Snavely, D., Wyatt-Knowles, E., Hale, J.J., Mills, S.G., MacCoss, M., Swain, C.J., Harrison, T., Hill, R.G., Hefti, F., Scolnick, E.M., Cascieri, M.A., Chicchi, G.G., Sadowski, S., Williams, A.R., Hewson, L., Smith, D., Carlson, E.J., Hargreaves, R.J. and Rupniak, N.M. (1998) Science, 281, 1640-5.
81. Ranga, K. and Krishnan, R (2002) J. Clin. Psychiatry, 63(Suppl 11), 25-9.
82. Meltzer, H.Y (2004) Nat. Med., 228.
83. Kramer, M.S., Winokur, A., Kelsey, J., Preskorn, S.H., Rothschild, A.J., Snavely, D., Ghosh, K., Ball, W.A., Reines, S.A., Munjack, D., Apter, J.T., Cunningham, L., Kling, M., Bari, M., Getson, A. and Lee, Y. (2004) Neuropsychopharmacology, 29, 385-92.
84. Chappell, P. (2002) 42nd Meeting of the New Clinical Drug Evaluation Unit.
85. Rupniak, N.M., Carlson, E.C., Harrison, T., Oates, B., Seward, E., Owen, S., de Felipe, C., Hunt, S. and Wheeldon, A. (2000). Neuropharmacology, 39, 1413-21.
86. Steinberg, R., Alonso, R., Rouquier, L., Desvignes, C., Michaud, J.C., Cudennec, A., Jung, M., Simiand, J., Griebel, G., Emonds-Alt, X., Le Fur, G. and Soubrie, P. (2002) J. Pharmacol. Exp. Then., 303, 1180-8.
87. Hutson, P.H., Patel, S., Jay, M.T. and Barton, C.L. (2004) Eur. J. Pharmacol., 484, 57-64.
88. Varty, G.B., Cohen-Williams, M.E. and Hunter, J.C. (2003) Behav. Pharmacol., 14, 87-95.
89. Dableh, L.J., Yashpal, K., Rochford, J. and Henry, J.L. (2005) Eur. J. Pharmacol., 507, 99-105.
90. Rupniak, N.M. (2002) Curr. Opin. Investig. Drugs, 3, 257-61.
91. Maubach, K.A., Martin, K., Chicchi, G., Harrison, T., Wheeldon, A., Swain, C.J., Cumberbatch, M.J., Rupniak, N.M. and Seabrook, G.R. (2002) Neuroscience, 109, 609-17.
92. Haddjeri, N. and Blier, P. (2000) Neuroreport, 11, 1323-7.
93. Invernizzi, R., Bramante, M. and Samanin, R. (1994) Eur. J. Pharmacol., 260, 243-6.
94. Hervas, I., Vilaro, M.T., Romero, L., Scorza, M.C., Mengod, G. and Artigas, F. (2001) Neuropsychopharmacology, 24, 11-20.
95. Dawson, L.A., Nguyen, H.Q., Smith, D.L. and Schechter, L.E. (2002) J. Psychopharmacol., 16, 145-52.
96. Newman, M.E., Shalom, G., Ran, A., Gur, E. and Van de Kar, L.D. (2004) Eur. J. Pharmacol, 486, 25-30.
97. Millan, M.J., Lejeune, F., De Nanteuil, G. and Gobert, A. (2001) J. Neurochem., 76, 1949-54.
98. Lejeune, F., Gobert, A. and Millan, M.J. (2002) Brain Res., 935, 134-9.
99. Zocchi, A., Varnier, G., Arban, R., Griffante, C., Zanetti, L., Bettelini, L., Marchi, M., Gerrard, P.A. and Corsi, M. (2003) Neurosci. Lett., 345, 73-6.
100. Conley, R.K., Cumberbatch, M.J., Mason, G.S., Williamson, D.J., Harrison, T., Locker, K., Swain, C., Maubach, K., O'Donnell, R., Rigby, M., Hewson, L., Smith, D. and Rupniak, N.M. (2002) J. Neurosci., 22, 7730-6.
101. Haddjeri, N. and Blier, P. (2001) Biol. Psychiatry, 50, 191-9.
102. Blier, P., Gobbi, G., Haddjeri, N., Santarelli, L., Mathew, G. and Hen, R. (2004) J. Psychiatry Neurosci., 29, 208-18.
103. Herpfer, I., Hunt, S.P. and Stanford, S.C. (2005) Neuropharmacology, 48, 706-19.
104. Guiard, B., Froger, N., Hamon, M., Lanfumey, L. and Gardier, A. (2005) J. Neurochem., (in press).
105. Casanovas, J.M. and Artigas, F. (1996) J. Neurochem., 67, 1945-52.
106. Matos, F.F., Urban, C. and Yocca, F.D. (1996) J. Neural. Transm., 103, 173-90.
107. Bel, N. and Artigas, F. (1993) Synapse, 15, 243-5.
108. Bortolozzi, A. and Artigas, F. (2003) Neuropsychopharmacology, 28, 421-34.
109. Adell, A. (2004) Curr. Drug Targets CNS Neurol. Disord., 3, 113-21.
110. Santarelli, L. and Saxe, M.D. (2003) CNS Spectr., 8, 589-96.
111. Lejeune, F., Gobert, A. and Milian, M. (2003) 33rd Annual Meeting of Neuroscience, Abs: 889.22.
112. Invernizzi, R., Velasco, C., Bramante, M., Longo, A. and Samanin, R. (1997) Neuropharmacology, 36, 467-73.
113. Malagie, I., Trillat, A.C., Douvier, E., Anmella, M.C., Dessalles, M.C., Jacquot, C. and Gardier, A.M. (1996) Naunyn. Schmiedebergs Arch. Pharmacol., 354, 785-90.
114. Taber, M.T., Kinney, G.G., Pieschl, R.L., Yocca, F.D. and Gribkoff, V.K. (2000) Synapse, 38, 17-26.
115. Gardner, C.J., Armour, D.R., Beattie, D.T., Gale, J.D., Hawcock, A.B., Kilpatrick, G.J., Twissell, D.J. and Ward, P. (1996) Regul. Pept., 65, 45-53.
116. Hrdina, P.D., Foy, B., Hepner, A. and Summers, R.J. (1990) J. Pharmacol Exp. Ther., 252, 410-8.
117. Boyce, S., Smith, D., Carlson, E., Hewson, L., Rigby, M., O'Donnell, R., Harrison, T. and Rupniak, N.M. (2001) Neuropharmacology, 41, 130-7.
118. Ebner, K., Rupniak, N.M., Saria, A. and Singewald, N. (2004) Proc. Natl. Acad. Sci. USA, 101, 4280-5.
119. Smith, D.W., Hewson, L., Fuller, P., Williams, A.R., Wheeldon, A. and Rupniak, N.M. (1999) Brain Res., 848, 90-5.
120. Culman, J., Klee, S., Ohlendorf, C. and Unger, T. (1997) J. Pharmacol. Exp. Ther., 280, 238-46.
121. Castren, E. (2004) Mol. Neurobiol., 29, 289-302.
122. Malberg, J.E., Eisch, A.J., Nestler, E.J. and Duman, R.S. (2000) J. Neurosci., 20, 9104-10.
123. Nibuya, M., Morinobu, S. and Duman, R.S. (1995) J. Neurosci., 15, 7539-47.
124. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R, Arancio, O., Belzung, C. and Hen, R. (2003) Science, 301, 805-9.
125. Morcuende, S., Gadd, C.A., Peters, M., Moss, A., Harris, E.A., Sheasby, A., Fisher, A.S., De Felipe, C., Mantyh, P.W., Rupniak, N.M., Giese, K.P. and Hunt, S.P. (2003) Eur. J. Neurosci., 18, 1828-36.
126. Czeh, B., Simon, M., van der Hart, M.G., Schmelting, B., Hesselink, M.B. and Fuchs, E. (2005) Neuropsychopharmacology, 30, 67-79.
127. Guest, P.C., Knowles, M.R., Molon-Noblot, S., Salim, K., Smith, D., Murray, F., Laroque, P., Hunt, S.P., De Felipe, C., Rupniak, N.M. and McAllister, G. (2004) Brain Res., 1002, 1-10.
128. Monteggia, L.M., Barrot, M., Powell, C.M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R.W. and Nestler, E.J. (2004) Proc. Natl. Acad. Sci. USA, 101, 10827-32.
129. Sairanen, M., Lucas, G., Ernfors, P., Castren, M. and Castren, E. (2005) J. Neurosci., 25, 1089-94.
130. Altieri, M., Marini, F., Arban, R, Vitulli, G. and Jansson, B.O. (2004) Brain Res., 1000, 148-55.
131. Hof, PR, Young, W.G., Bloom, F.E., Belichenko, P.V. and Celio M.R. (2000) Comparative Cytoarchitectonic Altlas of the C57BL/6 and 129/Sv Mouse Brains, New York: Elsevier.
132. Artigas, F. (1993) Trends Pharmacol. Sci.,14, 262.